Patrick Wood
Stock Analyst at Morgan Stanley
(3.05)
# 1,267
Out of 5,124 analysts
118
Total ratings
48.89%
Success rate
1.17%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Maintains: Equal-Weight | $76 → $83 | $81.96 | +1.27% | 7 | Dec 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $123 → $135 | $121.65 | +10.97% | 3 | Dec 2, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $17 → $23 | $21.98 | +4.64% | 6 | Dec 2, 2025 | |
| RXST RxSight | Maintains: Equal-Weight | $9 → $10 | $10.42 | -4.03% | 3 | Dec 2, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $56 → $51 | $31.46 | +62.11% | 4 | Dec 2, 2025 | |
| DXCM DexCom | Upgrades: Overweight | $63 → $75 | $66.37 | +13.00% | 10 | Dec 2, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $197 → $210 | $194.07 | +8.21% | 6 | Dec 2, 2025 | |
| BAX Baxter International | Maintains: Underweight | $19 → $15 | $19.11 | -21.51% | 6 | Dec 2, 2025 | |
| BLCO Bausch + Lomb | Upgrades: Overweight | $14 → $21 | $17.08 | +22.95% | 9 | Dec 2, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $80 | $82.02 | -2.46% | 8 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $130 | $95.35 | +36.34% | 7 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $84 → $80 | $78.81 | +1.51% | 5 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $276 → $295 | $253.52 | +16.36% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $75 → $81 | $85.25 | -4.99% | 9 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $79.24 | +29.98% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $112.91 | -36.23% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $122.04 | +41.76% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $284.24 | +11.53% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $2.17 | +360.83% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $23.09 | +60.24% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $113.61 | - | 5 | Dec 11, 2017 |
The Cooper Companies
Dec 8, 2025
Maintains: Equal-Weight
Price Target: $76 → $83
Current: $81.96
Upside: +1.27%
TransMedics Group
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $123 → $135
Current: $121.65
Upside: +10.97%
Tandem Diabetes Care
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $17 → $23
Current: $21.98
Upside: +4.64%
RxSight
Dec 2, 2025
Maintains: Equal-Weight
Price Target: $9 → $10
Current: $10.42
Upside: -4.03%
PROCEPT BioRobotics
Dec 2, 2025
Maintains: Overweight
Price Target: $56 → $51
Current: $31.46
Upside: +62.11%
DexCom
Dec 2, 2025
Upgrades: Overweight
Price Target: $63 → $75
Current: $66.37
Upside: +13.00%
Becton, Dickinson and Company
Dec 2, 2025
Maintains: Overweight
Price Target: $197 → $210
Current: $194.07
Upside: +8.21%
Baxter International
Dec 2, 2025
Maintains: Underweight
Price Target: $19 → $15
Current: $19.11
Upside: -21.51%
Bausch + Lomb
Dec 2, 2025
Upgrades: Overweight
Price Target: $14 → $21
Current: $17.08
Upside: +22.95%
GE HealthCare Technologies
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $74 → $80
Current: $82.02
Upside: -2.46%
Oct 23, 2025
Maintains: Overweight
Price Target: $125 → $130
Current: $95.35
Upside: +36.34%
Aug 21, 2025
Maintains: Equal-Weight
Price Target: $84 → $80
Current: $78.81
Upside: +1.51%
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $253.52
Upside: +16.36%
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $85.25
Upside: -4.99%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $79.24
Upside: +29.98%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $112.91
Upside: -36.23%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $122.04
Upside: +41.76%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $284.24
Upside: +11.53%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $2.17
Upside: +360.83%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $23.09
Upside: +60.24%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $113.61
Upside: -